Thomas E. Olencki, DO

Arthur G. James Cancer Hospital ...Columbus, Ohio - 43210-1240 (866-627-7616) The Ohio State University - ...Columbus, Ohio - 43210 (866-627-7616) |
- CLINICAL TRIALS 3
- CONDITIONS10
- INTERVENTIONS10
- SINCE2008

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By Surgery
August 2008 - August 2012

Study of MDX-1105 in Subjects With Selected Advanced or Recurrent Solid Tumors
April 2009 - June 2012

PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer
February 2008 - June 2009
Lung Neoplasms
Adenocarcinoma
Ovarian Neoplasms
Carcinoma, Renal Cell
Kidney Neoplasms
Carcinoma
Carcinoma, Non-Small-Cell Lung
Melanoma
Colorectal Neoplasms
Eye Neoplasms
Laboratory Biomarker Analysis
Immunoenzyme Technique
Gene Expression Analysis
Polymerase Chain Reaction
Flow Cytometry
Reverse Transcriptase-Polymerase Chain Reaction
Sorafenib Tosylate
Paclitaxel Albumin-Stabilized Nanoparticle Formulation
Peg-Interferon Alfa-2b
Mdx-1105



